(Former) HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Opioids and Controlled Substances
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, HIS, OS, OSG, SAMHSA
|
NIDA, OD/ OSP
|
2009
|
|
12th Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
NCCIH, NCI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR
|
2014
|
|
2020 Surgeon General's Report on Oral Health
|
Resource Development
|
OASH
|
NIDCR
|
2018
|
|
3rd National Conference on Advancing Early Psychosis Care in the United States: Addressing Inequities - Race, Culture, and COVID
|
Meeting/ Workshop
|
SAMHSA
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
NCI
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
NCI
|
2019
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
NCI
|
1998
|
|
A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
CC
|
2011
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Therapeutics Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Accelerating Medicines Partnership (AMP)
|
Other
|
FDA
|
NIA, NIDDK, NIAMS, NINDS, NIMH, OD/ OSP
|
2014
|
|
Accelerating Medicines Partnership Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
AccessGUDID
|
Resource Development
|
FDA, GDM
|
NLM
|
2015
|
|
ACL Advisory Council on Grandparents Raising Grandchildren
|
Committee, Advisory Group, or Work Group
|
ACL, ACF, SAMHSA, CDC, HRSA, ASPE, ONC
|
NIA
|
2019
|
|
Action for Health in Diabetes Extension (Look AHEAD-E)
|
Research Initiative
|
CDC, IHS
|
NIA, NIDDK
|
1999
|
|
Acute Flaccid Myelitis (AFM) Studies
|
Research Initiative
|
CDC
|
NIAID, NICHD, NINDS
|
2018
|
|
Acute Flaccid Myelitis (AFM) Workshop Planning Committee
|
Meeting/ Workshop
|
CDC
|
NIAID, NICHD, NINDS
|
2019
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NIAID
|
2013
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advanced Viral Detection Technology IG (AVDTIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2018
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, HIS, OCR
|
NIDDK, NIEHS
|
2019
|
|
Advancing Protection and Care for Children in Adversity: A U.S. Government Strategy for International Assistance (APCCA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NICHD, NIMH
|
2019
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
CC, NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborn and Children
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NHLBI, NICHD, NIDDK, NLM
|
2014
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID
|
2009
|
|
Advisory Council on Blood Stem Cell Transplantation (ACBSCT) of the U.S. Department of Health and Human Services (HHS)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA
|
NHLBI
|
2008
|
|
Aging and Disability Federal Partners Working Group
|
Committee, Advisory Group, or Work Group
|
ASPE
|
NIA
|
|
|
Alaska Native Tumor Registry
|
Resource Development
|
CDC, IHS
|
NCI
|
1999
|
|
Alzheimers.gov Collaborations with Federal Agencies
|
Public Education Campaign
|
ACL, ASPA, ASPE, CDC
|
NIA, NINDS
|
2020
|
|
America's Children Forum on Health and Family Statistics
|
Resource Development
|
SAMHSA
|
NIDA
|
1994
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Nutrition
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Committee on Pediatric AIDS
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Genetics
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
American Academy of Pediatrics (AAP) Council on Injury, Violence and Poison Prevention (COIVPP)
|
Committee, Advisory Group, or Work Group
|
ACF, HRSA, IHS
|
NICHD
|
2011
|
|
American Academy of Pediatrics (AAP) Section on Obesity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
American College of Obstetricians and Gynecologists (ACOG) Patient Education Review Panel
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Animal Care Radiation Models Meeting
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
2019
|
|
Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
FIC, NCI, NHGRI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NIMHD, NINR, OD/ DPCPSI/ OBSSR, ODP
|
2014
|
|
Antibody Interest Group (ABIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDCR, NIDDK
|
2010
|
|
Antimicrobial Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC
|
NICHD
|
1989
|
|
Arthritis Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
Asia-Pacific Economic Cooperation (APEC) Cervical Cancer Initiative
|
Meeting/ Workshop
|
OGA
|
NCI
|
2013
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|
Assisted Outpatient Treatment for Individuals with Serious Mental Illness
|
Research Initiative
|
HRSA, SAMHSA, ASPE
|
NIMH
|
2016
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Bacteriophage Interest Group (Monthly Meeting)
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID
|
2016
|
|
Bacteriophage Therapy: Intraagency meeting
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2018
|
|
Bench to Bedside: Integrating Sex and Gender to Improve Human Health
|
Resource Development
|
FDA
|
OD/ DPCPSI/ ORWH
|
2017
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NICHD
|
2009
|
|
Bi-Weekly Assay subgroup for SARS-CoV-2
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, BARDA, FDA
|
NIAID
|
2020
|
|
BioCompute Object Project
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2018
|
|
Biodefense Coordination Team (BCT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
2019
|
|
Bioeconomy Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Biological Select Agents and Toxins Interagency Policy Committee (BSAT PPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
|
|
Biological Select Agents and Toxins sub-Interagency Policy Committee (BSAT Sub-PPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
|
|
Biomarkers of Exposure and Effect in Agriculture (BEEA)
|
Research Initiative
|
CDC
|
NCI
|
2018
|
|
Biomarkers of Radiation injury Meeting
|
Meeting/ Workshop
|
ASPR, FDA
|
NIAID
|
2019
|
|
Biomarkers, EndpointS, and other Tools (BEST) Resource Glossary
|
Resource Development
|
FDA
|
NCI
|
2016
|
|
Blood Products Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, NHLBI
|
2011
|
|
Blood, Organ, and Tissue Safety Committee (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
1997
|
|
Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CC, NIAID
|
2012
|
|
Board of Scientific Counselors (BSC) of the CDC's National Center for Injury Prevention and Control
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIA, NICHD, NIDA, NIMH
|
2011
|
|
Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
Botanical Safety Consortium
|
Research Initiative
|
FDA
|
NCCIH, NEIHS
|
2019
|
|
Botulism Guidelines Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC
|
2016
|
|
Brain Attack Coalition (BAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NINDS
|
1997
|
|
Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
|
Research Initiative
|
FDA
|
NCCIH, NEI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2014
|
|
Canadian - U.S. Dietary Reference Intakes Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI
|
2005
|
|
Cancer Control Plan, Link, Act, Network with Evidence-Based Tools (P.L.A.N.E.T)
|
Resource Development
|
AHRQ, CDC
|
NCI
|
2003
|
|
Cancer Moonshot Award
|
Research Initiative
|
OS
|
NCI, NIDCD
|
2019
|
|
CDC Acute Flaccid Myelitis Task Force
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2018
|
|
CDC Chronic Kidney Disease Surveillance
|
Health Survey
|
CDC
|
NIDDK
|
2006
|
|
CDC Integration with GrantSolutions
|
Resource Development
|
ACF, CDC
|
OD/ OER
|
2016
|
|
CDC Office of Public Health Genomics
|
Public Education Campaign
|
CDC
|
NHLBI
|
2017
|
|
CDC-NIH Lyme Disease Serum Sample Repository
|
Resource Development
|
CDC, OS
|
NIAID
|
2008
|
|
CDC/RAND Technical Expert Panel on Behavioral Health Surveillance in Disasters
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIMH
|
2020
|
|
Cervical screening guidelines
|
Resource Development
|
CDC, HRSA, FDA
|
NCI
|
2019
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
CHEMM (Chemical Hazards Emergency Medical Management)
|
Resource Development
|
ATSDR, CDC, IOS
|
NICHD, NLM
|
2008
|
|
Cherokee Cancer Registry (CNCR)
|
Resource Development
|
IHS
|
NCI
|
1997
|
|
Childhood Cancer Data Initiative (CCDI), National Childhood Cancer Registry (NCCR)
|
Resource Development
|
CDC
|
NCI
|
2020
|
|
Children's HHS Interagency Leadership on Disasters (CHILD) Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OS, SAMHSA
|
NIAID, NICHD, NIDA, NIGMS, NIMH
|
2010
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
NCI
|
2018
|
|
CLARITY - Mammary Gland efforts
|
Research Initiative
|
ATSDR
|
NIEHS
|
2016
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
2016
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC
|
2013
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, IOS
|
NLM
|
2008
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ OLPA, OD/ OSP
|
2000
|
|
CMS End-stage Renal Disease (ESRD) Affinity Group
|
Committee, Advisory Group, or Work Group
|
CMS
|
NIDDK
|
2016
|
|
CMS-NIH Leadership Council
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/ IMOD, OD/ OER, OD/ OSP
|
2011
|
|
Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2020
|
|
Collaborative Acute Toxicity Modeling Suite (CATMoS)
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC
|
NCATS, NIEHS
|
2018
|
|
Collaborative on Healthy Parenting in Primary Care
|
Public Education Campaign
|
CDC, HRSA, SAMHSA
|
NICHD
|
|
|
Collaborative Use Repurposing Engine ID (CURE ID)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Combating Antibiotic Resistant Bacteria (CARB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NIAID, NLM
|
2015
|
|
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) Joint Oversight Committee
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
NIAID
|
2016
|
|
Community Engagement Alliance Against COVID-19 Disparities (CEAL) Initiative
|
Research Initiative
|
AoA
|
NICHD, OD/ DPCPSI/ ORWH
|
2020
|
|
Community Guide Cardiovascular Coordination Team
|
Committee, Advisory Group, or Work Group
|
CDC
|
NHLBI
|
2013
|
|
Community Preventive Services Task Force (CPSTF)
|
Committee, Advisory Group, or Work Group
|
CDC
|
OD/ DPCPSI, ODP
|
1996
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Congenital Heart Public Health Consortium
|
Resource Development
|
AHRQ, CDC
|
NHLBI
|
2008
|
|
CONSUMER PRODUCT CHEMICAL EXPOSURES IN PREGNANCY AND THEIR CUMULATIVE IMPACT ON DISORDERS OF FETAL GROWTH
|
Research Initiative
|
CDC
|
NIEHS
|
2020
|
|
Contract to fund Congressional mandated National Academies of Sciences, Engineering, and Medicine (NASEM) study on Organ Donation and Transplantation
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NHLBI, NIAID, NIDDK
|
2019
|
|
COPD National Action Plan
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, HRSA, IHS
|
NCI, NHLBI, NIA, NIEHS, NINR
|
2017
|
|
Council on Emergency Medical Care (CEMC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, HRSA, OS, SAMHSA
|
NCATS, NHLBI, NICHD, NIGMS, NIMH, NINDS, NLM
|
2006
|
|
Countering Biothreats PCC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countering Biothreats sub-PCC on Promoting and Protecting the Bioeconomy
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
OD/ OSP
|
2019
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network
|
Research Initiative
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2006
|
|
Country Work in Cancer Research and Cancer Control Planning Strengthening; Kenya
|
Research Initiative
|
CDC
|
FIC, NCI, NIAID
|
2013
|
|
COVID CDEs (caDSR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIMHD, NIMH, NIGMS, NIDDK, NIDCR, NIEHS, NINDS, NINR, NLM, OD/ OER, OD/ DPCPSI/ ODSS, OD/ DPCPSI/ OBSSR, OD
|
2020
|
|
COVID-19 Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCATS, CC, CIT, NCI, NHGRI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, NLM, OD
|
2020
|
|
COVID-19 Therapeutics Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIAID
|
2020
|
|
Critical Crossroads Federal Steering Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH, NINDS
|
|
|
Cytokine Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NEI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCR
|
2007
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Data Access for Grantees
|
Resource Development
|
CMS
|
NIA
|
2010
|
|
Demand Reduction Interagency Working Groups
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Department of Defense Resuscitation and Transfusion Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2012
|
|
Department of Health and Human Services (DHHS) Health Care Personnel Influenza Vaccination Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
CC
|
2008
|
|
Department of Health and Human Services (DHHS) Healthcare Infection Control Practices Advisory Committee (HICPAC)
|
Committee, Advisory Group, or Work Group
|
OS
|
CC
|
2005
|
|
Department of Health and Human Services (DHHS) Medical Claims Review Panel
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC
|
1990
|
|
Department of Health and Human Services (DHHS) Steering Committee for the Prevention of Healthcare-Associated Infections
|
Committee, Advisory Group, or Work Group
|
OS
|
CC
|
2008
|
|
Department of Health and Human Services (HHS) Biovigilance Committee
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NHLBI
|
2009
|
|
Developing Clinical Vocabulary Standards for Public Health Reporting
|
Resource Development
|
CDC
|
NLM
|
2010
|
|
Development and Use of a Non-human Primate Model of Pertussis Disease and Transmission
|
Other
|
FDA
|
NIAID
|
2011
|
|
Development of New Approach Methodologies to Reduce Animal Use in Toxicity Testing -SBIR/STTR Town Hall Meeting
|
Meeting/ Workshop
|
FDA
|
NIEHS
|
2020
|
|
Developmental Considerations of Antifungal Drugs to Address Unmet Medical Need
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2020
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OASH
|
NIDDK
|
1974
|
|
Diabetes Prevention Program Outcomes Study (DPP/DPPOS)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NIDDK, NIA
|
1994
|
|
Diabetic Eye Disease Information Dissemination
|
Public Education Campaign
|
CDC
|
NEI
|
2015
|
|
Diabetic Retinopathy Clinical Research Network
|
Research Initiative
|
OS
|
NEI, NIDDK
|
2002
|
|
Diagnosis, Treatment, and Medical Service Utilization in Medicare and Medicaid Population
|
Research Initiative
|
CMS
|
CC
|
2011
|
|
Diet-induced Hypomethylation in Preneoplastic Liver/Genetics & Epigenetics of Susceptibility to Non-Alcoholic Fatty Liver Disease
|
Research Initiative
|
FDA
|
NCI
|
2004
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Disaster Research Response Project (DR2)
|
Research Initiative
|
ATSDR, CDC, FDA, IOS
|
NIEHS, NLM, OD/ DPCPSI
|
2013
|
|
Drug Development Interest Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC
|
FIC, NCI, NHLBI, NIAID
|
2015
|
|
Drug Induced Liver Injury Network (DILIN)
|
Resource Development
|
FDA
|
NCI, NIDDK
|
2003
|
|
E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI): Developing a Research Agenda
|
Meeting/ Workshop
|
CDC, FDA
|
NCI, NHLBI, NIDA
|
2019
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC, HRSA
|
NIDCD
|
2007
|
|
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite with Coordinating Center
|
Research Initiative
|
HRSA
|
NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, ODP
|
2019
|
|
Ebola Clinical Research Response in Democratic Republic of the Congo
|
Research Initiative
|
CDC
|
NIAID
|
2018
|
|
Ebola Clinical Research Response in West Africa (Guinea, Liberia)
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
Ebola Vaccines Advisory Committee on Immunization Practises (ACIP) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2020
|
|
eCare Plan for People with Multiple Chronic Conditions Project
|
Committee, Advisory Group, or Work Group
|
AHRQ, CMS, FDA, HRSA, ASPE, ACL
|
NCI, NIA, NIDDK, NLM
|
2019
|
|
Emergency Preparedness, Medical Countermeasures
|
Resource Development
|
OS
|
NCI
|
2007
|
|
End-stage Renal Disease Collaboration
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NIBIB, NIDDK
|
2016
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
|
|
Environmental Phthalate Exposures in Pregnancy in Relation to Fetal and Placental Development
|
Research Initiative
|
CDC
|
NIEHS
|
2020
|
|
Evidence-Based Cancer Control Programs
|
Resource Development
|
CDC
|
NCI
|
2003
|
|
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
|
Research Initiative
|
CDC
|
NIA
|
2019
|
|
Extracellular Ribonucleic Acid (RNA) Communication
|
Research Initiative
|
FDA
|
NCATS, OD/ DPCPSI/ OSC
|
2013
|
|
Extracting Adverse Reactions and Indexing the Content of Structured Product Labels (SPLs)
|
Resource Development
|
FDA
|
NLM
|
2016
|
|
Extraction of adverse drug events from MEDLINE indexing to support a multimodal model for pharmacovigilance.
|
Resource Development
|
FDA
|
NLM
|
2012
|
|
Extramural Interagency Filovirus Team
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2019
|
|
Eye Research Collaboration
|
Research Initiative
|
FDA
|
NEI
|
2014
|
|
Factor VIII Inhibitors: Generating a National Blueprint for Future Research
|
Meeting/ Workshop
|
CDC
|
NCI, NHLBI, NICHD, NLM
|
2017
|
|
Fast Track Action Committee on Biosafety and Biosecurity (FTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2015
|
|
FDA Acute Radiation Syndrome (ARS) Action Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NIAID
|
2018
|
|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
2011
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
CC
|
2020
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA Risk Evaluations and Midigation workshop (FDA REMS)
|
Meeting/ Workshop
|
FDA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
FDA Uterine Fibroids Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, OD/ DPCPSI/ ORWH
|
2017
|
|
FDA-NIH Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/ IMOD, OD/ OER, OD/ OSP
|
2010
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH
|
2020
|
|
Federal Consortium on the Substance Abusing Offender
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIDA
|
2003
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NHLBI, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ONR
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal Health IT Coordinating Council
|
Committee, Advisory Group, or Work Group
|
CMS, ONC
|
NLM
|
|
|
Federal Health IT Coordinating Council (FHIT CC): Fast Healthcare Interoperability Resources (FHIR®) Work Group
|
Committee, Advisory Group, or Work Group
|
ONC, CMS
|
NHGRI
|
2020
|
|
Federal Health IT Coordinating Council (FHIT CC): United States Core Data for Interoperability (USCDI)
|
Committee, Advisory Group, or Work Group
|
ONC
|
NHGRI
|
2020
|
|
Federal HIV Implementation Science Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2018
|
|
Federal HIV Web Council (FHWC) (HIV.gov)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, FDA, HRSA, IHS, SAMHSA, ACF
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Hypertension Control Leadership Council
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, ASPR, ONC
|
NHLBI, NINDS
|
2020
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Forum for Child and Family Statistics
|
Research Initiative
|
ACF, AHRQ, CDC, HRSA, OS, SAMHSA
|
NICHD, NIMH
|
2010
|
|
Federal Interagency Forum on Aging Related Statistics
|
Resource Development
|
ACL, AHRQ, CDC, CMS, OS, SAMHSA
|
NIA
|
1986
|
|
Federal Interagency Task Force on the Arts and Human Development
|
Research Initiative
|
ACF, ACL, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Federal Interagency Traumatic Brain Injury Research (FITBIR) Working Group
|
Resource Development
|
AHRQ, CDC, HRSA, OS, SAMHSA
|
CIT, NCATS, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIGMS, NIMH, NINDS
|
2008
|
|
Federal Interagency Workgroup on Autism Spectrum Disorders (FIWA)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, CMS, HRSA, IHS, SAMHSA, ASPE
|
NIMH, NINDS
|
2018
|
|
Federal Interagency Workgroup on Child Abuse and Neglect (FEDIAWG)
|
Committee, Advisory Group, or Work Group
|
ACF
|
NIAAA, NICHD, NIDA, NIMH, OD/ DPCPSI/ OBSSR
|
1998
|
|
Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care.
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, ONC, SAMHSA
|
NIBIB, NLM, CC, NCATS, NCI
|
2018
|
|
Federal Interagency Workgroup on Teen Dating Violence
|
Committee, Advisory Group, or Work Group
|
ACF, CDC
|
NICHD
|
2006
|
|
Federal Interagency Working Group on Measuring Sexual Orientation and Gender Identity (SOGI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CMS, SAMHSA
|
NICHD, OD/ DPCPSI/ SGMRO
|
2015
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NICHD
|
|
|
Federal Partners in Bullying Prevention
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS, SAMHSA
|
NIAAA, NICHD, NIDA, OD/ DPCPSI/ OBSSR
|
|
|
Federal RePORTER
|
Resource Development
|
ACF, ACL, AHRQ, CDC, FDA
|
OD/ OER
|
2008
|
|
Federal Sudden Unexpected Infant Death/Sudden Infant Death Syndrome (SUID/SIDS) Workgroup
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, IHS
|
NICHD
|
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NEI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Meeting/ Workshop
|
AHRQ, CDC, HRSA, IHS, FDA
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
2005
|
|
federated learning across Health Information Exchanges (HIE)
|
Committee, Advisory Group, or Work Group
|
ONC
|
NCI
|
2020
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
FNIH Advanced Medicines Partnership on Gene Therapy
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
FNIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NINDS
|
2006
|
|
Focus on Aging: Federal Partners Webinar Series
|
Public Education Campaign
|
ACL, CDC, HRSA
|
NIA
|
2017
|
|
Foundation for the National Institutes of Health (FNIH) PACT (Partnership for Accelerating Cancer Therapies)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2017
|
|
Full-text health-related documents at NLM (includes HSTAT) Bookshelf/Digital Repository
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, SAMHSA
|
NLM
|
1994
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF, ACL, AHRQ, CDC, CMS, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, , NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ AoU, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ DPCPSI/ THRO, OD/ DPCPSI/ SGMRO, OD/ ECHO, OD/ IMOD, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ ORS, OD/ OSP, ODP
|
2016
|
|
Funding Opportunity Announcement: Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)
|
Other
|
IHS
|
NCI, NIGMS, NHLBI, NHGRI, NIA, NIAID, NIAMS, NIDCR, NIDDK, NIDA, NIMHD, NCCIH, NICHD, NIEHS, OD/ DPCPSI/ ORWH
|
2020
|
|
Gabriella Miller Kids First Common Fund Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/ DPCPSI/ ORIP
|
2015
|
|
Genetic Studies in the National Birth Defects Prevention Study (NBDPS)
|
Research Initiative
|
CDC
|
NHGRI
|
2014
|
|
Genome in a Bottle Consortium (GIAB)
|
Resource Development
|
CDC, FDA
|
NCI, NHGRI, NLM
|
2013
|
|
Genomic Surveillance at US Swine Fairs
|
Resource Development
|
CDC
|
FIC, NIAID
|
2009
|
|
GeT-RM Browser
|
Resource Development
|
CDC
|
NLM
|
2012
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Research Initiative
|
CDC
|
FIC, NCI, NIEHS, OD/ DPCPSI/ ORWH
|
2011
|
|
Global Health - Household Air Pollution Investigation Network (HAPIN)
|
Research Initiative
|
CDC
|
FIC, NCI, NHLBI, NICHD, NIEHS, OD/ DPCPSI/ OSC
|
2016
|
|
Global Health Security Agenda (GHSA) Action Package Prevent 3 (APP3), Biosafety and Biosecurity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2014
|
|
Global Ingredient Archival System (GINAS)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Global Initiative for Cancer Registry Development
|
Resource Development
|
CDC
|
NCI
|
2014
|
|
Global Strategic Plan to Prevent Harms Associated with Alcohol Misuse
|
Meeting/ Workshop
|
CDC, SAMHSA
|
NIAAA, NICHD, NIDA, ODP
|
2009
|
|
Harmonization of various Common Data Models and Open Standards for Evidence Generation
|
Resource Development
|
FDA
|
NCATS, NCI, NLM
|
2016
|
|
HCS Research Collaboratory
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, OS
|
OD/ DPCPSI/ OSC, ODP
|
2012
|
|
Health and Retirement Study (HRS)
|
Research Initiative
|
CDC, CMS
|
NIA
|
1992
|
|
Health Information National Trends Survey (HINTS)
|
Health Survey
|
ONC
|
NCI
|
2015
|
|
Health Information Technology Advisory Committee (HIT)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, IOS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2014
|
|
Health Information Technology Advisory Committee (HITAC)
|
Committee, Advisory Group, or Work Group
|
ONC
|
NLM
|
|
|
Health-professional Education Partnership Initiative (HEPI) and African Association for Health Professionals Education and Research (AFREHealth)
|
Training Initiative
|
OS
|
FIC, NINR
|
2018
|
|
HealthMap: Knowledge Management for Emerging Infectious Disease Intelligence
|
Research Initiative
|
IOS
|
NLM
|
2009
|
|
Healthy People 2020/2030 Heart Disease and Stroke Federal Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NHLBI, NINDS
|
2010
|
|
Healthy People 2030 - Cancer Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, , AHRQ, , OASH
|
NCI
|
2012
|
|
Healthy People 2030 - Heart Disease and Stroke Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS
|
NHLBI, NINDS
|
2000
|
|
Healthy People 2030 - Kidney Disease
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2030 - Nutrition and Weight Status Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OASH
|
NIDDK, OD/ DPCPSI/ ONR
|
2010
|
|
Healthy People 2030 - Respiratory Diseases
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Sleep Health
|
Health Survey
|
CDC
|
NHLBI, NIA, NICHD, NIDA, NIDDK, NIMHD, NINDS, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODS
|
2000
|
|
Healthy People 2030 - Social Determinants Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, HRSA, OASH, SAMHSA, PSC, FDA
|
NIA, NCI, NIAAA, NIMHD
|
2016
|
|
Healthy People 2030 Disability and Health Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NICHD
|
|
|
Healthy People Initiative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDCD, NIDDK, NIEHS, NIMH, NINDS, ODP
|
1979
|
|
Healthy People Initiative - Visual Health
|
Health Survey
|
AHRQ, CDC
|
NEI, ODP
|
2011
|
|
Healthy Vision Month
|
Public Education Campaign
|
CDC
|
NEI
|
2014
|
|
Helicobacter pylori Genome Project (HpGP)
|
Research Initiative
|
CDC
|
NCI, NLM
|
2016
|
|
Hepatitis B Research Network
|
Research Initiative
|
CDC
|
NCI, NIDDK
|
2008
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Adult Maltreatment Prevention Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, IHS, OS, SAMHSA
|
NIA
|
2018
|
|
HHS Antiretroviral Treatment Guidelines Panel for Adults and Adolescents with HIV
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC, FDA
|
NIAID
|
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biosafety and Biosecurity Coordinating Council (HHS BBCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ ORS, OD/ OSP
|
2015
|
|
HHS Border Health Intra-agency Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, FDA, HRSA, OS
|
NIA, NIAID, NICHD, NIDDK, NIMH, NIMHD
|
|
|
HHS Cessation Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, HRSA, CMS, FDA, SAMHSA, IOS
|
NCI, NIDA, NHLBI, NICHD
|
|
|
HHS DATA Act Compliance
|
Committee, Advisory Group, or Work Group
|
ASFR
|
OD/ OER, OD/ OM/ NBS
|
2020
|
|
HHS Data Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASFR, ASPA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, ONC, OMHA
|
NLM, OD/ DPCPSI/ OBSSR, OD/ OER, OD/ DPCPSI/ ODSS
|
1996
|
|
HHS Data Council Data-Oriented Workforce Subcommittee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA
|
NCATS, NLM, OD/ IMOD, OD/ OIR
|
2019
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OASH
|
NIDDK, OD/ DPCPSI/ ONR
|
1990
|
|
HHS Disability Collaborative
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPA, ASPE, ASFR, ASA, ASPR, ACF, CDC, CMS, OASH, OCR, ONC, OIG, OGA, HRSA, SAMHSA, FDA, IHS
|
NIA, NICHD
|
2020
|
|
HHS Environmental Justice and Natural Disasters Working Group (EJ)
|
Committee, Advisory Group, or Work Group
|
ASPR, OASH, CDC, HRSA
|
NIEHS
|
2012
|
|
HHS Global Health Collaborative
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
|
|
HHS Health Disparities Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIMHD
|
|
|
HHS HIV Bidirectional Meeting Planning Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAID, NIMH
|
2018
|
|
HHS Kidney Care Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
HHS LGBT Policies Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH, OD/ DPCPSI/ SGMRO
|
2011
|
|
HHS Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPE, ASFR, CDC, CMS, FDA, HRSA, IHS, ONC, IOS, ATSDR, SAMHSA
|
NICHD, OD/ DPCPSI/ ORWH, NHLBI
|
|
|
HHS Noise-Induced Hearing Loss Federal Partner Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2018
|
|
HHS Office on Women's Health, Section on Pregnancy and Newborn Care
|
Committee, Advisory Group, or Work Group
|
OS, SAMHSA
|
NICHD, NIMH
|
|
|
HHS Panel for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
|
Committee, Advisory Group, or Work Group
|
CDC
|
NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD, OD/ DPCPSI/ OAR
|
|
|
HHS Potential Pandemic Pathogens Care and Oversight Review Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2018
|
|
HHS SARS-CoV-2 Assay Development Task orders
|
Resource Development
|
BARDA
|
NIAID
|
2020
|
|
HHS SARS-CoV-2 Immune Assay Testing of Ph3 clinical samples- Task Order
|
Resource Development
|
BARDA
|
NIAID
|
2020
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIAID
|
2017
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDA, NIAID, NIDDK, OD/ DPCPSI/ OAR
|
2009
|
|
HHS Zika Vaccine Testing Task Orders Coordination
|
Resource Development
|
BARDA
|
NIAID
|
2016
|
|
HHS-NASA Scientific Potential/Actual Collaborative Efforts (SPACE) group
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA
|
FIC, NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINDS, OD/ IMOD
|
2019
|
|
HHS-wide Stigma Scientific Interest Group (Stigma SIG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, FDA, SAMHSA, IHS
|
FIC, NIMH, NCI, NIDA, NIAAA, NINDS, NICHD, OD/ DPCPSI/ OBSSR, NIMHD, NINR, NIAID, NIDCR
|
2020
|
|
HHS-Wide Stigma Workgroup
|
Resource Development
|
CDC, FDA, HRSA, IHS, SAMHSA
|
NIMH
|
2019
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
2017
|
|
HIV Implementation Science Summit for Ending the HIV Epidemic (EHE) Supplement Projects
|
Meeting/ Workshop
|
CDC, HRSA
|
NIAID, NICHD, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2019
|
|
HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in HRSA Primary Health Care Settings
|
Research Initiative
|
HRSA
|
NIMH
|
2020
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
NCI
|
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
2010
|
|
HRSA Advancing Precision Medicine (HRSA APM)
|
Committee, Advisory Group, or Work Group
|
HRSA
|
OD/ AoU
|
2017
|
|
HRSA Maternal and Child Health Bureau Grand Challenges: Promoting Pediatric Primary Prevention ("P4 Challenge") Federal Judge
|
Meeting/ Workshop
|
CDC, CMS, HRSA
|
NICHD
|
|
|
HRSA Maternal and Child Health Bureau Grand Challenges: remote pregnancy monitoring panelist
|
Research Initiative
|
CDC, CMS, HRSA
|
NICHD
|
|
|
HSS Maternal Mortality Working group
|
Committee, Advisory Group, or Work Group
|
HRSA, CDC
|
NICHD, OD/ DPCPSI/ ORWH
|
2019
|
|
Human Papillomavirus (HPV) Working Group for the Advisory Committee on Immunization Practices (ACIP)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI
|
2012
|
|
Human skin sensitization data set
|
Research Initiative
|
FDA
|
NIEHS
|
2020
|
|
I-Corps @ NIH
|
Training Initiative
|
CDC
|
NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINDS
|
2015
|
|
IAA with FDA - Using big data to compare SARS-CoV-2 infection and therapeutic efficacy between human lung on a chip and animal model testing
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
ICCVAM Ecotoxicology Workgroup (EcoWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS
|
2018
|
|
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NIEHS, NLM
|
2017
|
|
ICCVAM Metrics Workgroup (MWG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS, OD
|
2019
|
|
ICCVAM Nanomaterials Workgroup (NanoWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIEHS
|
2018
|
|
ICCVAM Public Forum
|
Meeting/ Workshop
|
FDA
|
NCATS, NIEHS
|
2014
|
|
ICCVAM Read Across Workgroup (RAWG)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA
|
NIEHS, NLM
|
2017
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Immunology Interest Group
|
Meeting/ Workshop
|
FDA
|
NIDDK, NCI, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI
|
1990
|
|
Implementation Research in HRSA Ryan White Sites: Screening and Treatment for Mental and Substance Use Disorders to Further the National “Ending the HIV Epidemic” (EHE) Goals
|
Research Initiative
|
HRSA
|
NIDA, NIMH
|
2020
|
|
Implementing Early Intervention Services for Clinical High Risk for Psychosis in U.S. Community Settings: What Do We Know and What Do We Need to Know?
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
2016
|
|
Improving Genomics/Omics Technical Standards and Molecular Tools for Prebiotic Probiotic Research and Development Working Group
|
Research Initiative
|
CDC, FDA, OS
|
NCCIH, NCI, NHGRI, NIDA, NLM
|
2016
|
|
Improving Steps in the Development and Assessment of Live Microbiome-Based Products: Fecal Microbiota for Transplantation (FMT) and Live Biotherapeutic Products (LBPs)
|
Resource Development
|
FDA
|
NIAID
|
2019
|
|
In Vitro Assessment of Dermal Hypersensitivity: Using Alternative Methods to Predict Skin Sensitization
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
Inclusion Across the Lifespan
|
Meeting/ Workshop
|
FDA
|
NCI, NHLBI, NIA, NICHD, NIDCR, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ OER
|
2016
|
|
Incorporating a Sex-and Gender Lens from Bench to Bedside: Neurology
|
Meeting/ Workshop
|
FDA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
Industrywide exposure assessment study of workers exposed to graphene and other two-dimensional nanomaterials
|
Research Initiative
|
CDC
|
NIEHS
|
2018
|
|
Influenza Diagnostics Risk Management Meeting (FRMM) Strategy Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Inter-Agency Working Group on the National Healthcare Quality and Disparities Report
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, IHS, OS
|
NCI, NHLBI, NIMHD, OD/ DPCPSI
|
2015
|
|
Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
CC, NCATS, NCI, NEI, NHGRI, NHLBI, NIAAA, NICHD, NLM
|
2013
|
|
Interagency Adult Literacy Research Group
|
Committee, Advisory Group, or Work Group
|
ACF
|
NICHD
|
2014
|
|
Interagency Agreement
NTP/NIEHS and NCTR/FDA (IAA)
|
Other
|
FDA
|
NIEHS
|
1993
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NICHD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Biodefense Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
FIC, NIAID, NIEHS, NLM, OD/ OM/ OB, OD/ ORS, OD/ OSP
|
2018
|
|
InterAgency Board (IAB)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
2010
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAID, NINDS
|
2010
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
BARDA, CDC, FDA
|
OD/ OER
|
2016
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NICHD, NIDCD, NIMH, NINDS
|
1988
|
|
Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIDDK, NCI, OD/ DPCPSI, OD/ DPCPSI/ ONR
|
2013
|
|
Interagency Committee on Smoking and Health
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
1985
|
|
Interagency Committee on the American Community Survey (ACS)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, HRSA, OS
|
NICHD
|
2005
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASA, ASPE, ASPR, ATSDR, CDC, CMS, FDA, GDM, HRSA, IHS, IOS, OASH, OCIIO, OCR, OGA, OIG, OMHA, ONC, ORAC, PHSSEF, PSC, SAMHSA, AoA, OPHS
|
NIAAA, NIMH, NIDA, NICHD
|
1996
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
Interagency Coordinating Committee on the Prevention of Underage Drinking (ICCPUD)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA
|
2004
|
|
Interagency Coordinating Committee on the Validation of Alternative Toxicological Methods (ICCVAM)
|
Committee, Advisory Group, or Work Group
|
ATSDR, FDA, CDC
|
NCI, NIEHS, NLM, OD
|
2003
|
|
Interagency Elder Justice Working Group (EJWG)
|
Committee, Advisory Group, or Work Group
|
ACL
|
NIA
|
2016
|
|
Interagency Group for Development of Lung Infection Models for P. aeruginosa and A.baumannii
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
CSR, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR
|
2003
|
|
Interagency Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID, NINDS
|
2020
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OM/ OB, OD/ OSP
|
2011
|
|
Interagency Serological Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2018
|
|
Interagency Task Force on Military and Veterans Mental Health (ITF)
|
Committee, Advisory Group, or Work Group
|
ACL, OS, SAMHSA
|
NIMH
|
2012
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, SAMHSA
|
NCCIH, NCI, NIA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2011
|
|
Interagency Task Force on Trauma-Informed Care
|
Committee, Advisory Group, or Work Group
|
AHRQ, CMS, CDC, IHS, FDA, HRSA, OMHA, ACF, ASPE, OCR, SAMHSA
|
NICHD
|
2018
|
|
Interagency Workgroup on Coordinating Opportunities for Evaluating Dolutegravir and Neural Tube Defects Association
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIAID
|
2018
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Interagency Working Group in the Glycosciences
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Interagency working group on Biological Data Sharing
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIGMS
|
2018
|
|
Interagency Working Group on Harmful Algal Bloom and Hypoxia Research and Control Act (IWG-HABHRCA)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
NIEHS
|
2014
|
|
Interagency Working Group on Open Science
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CDC, FDA, OS
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
Interdepartmental Health Equity Collaborative (formerly FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, ODP
|
2006
|
|
Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC)
|
Committee, Advisory Group, or Work Group
|
CMS, SAMHSA
|
NIMH
|
2018
|
|
Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC)
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIDA
|
2019
|
|
International Cancer Control Partnership (ICCP)
|
Other
|
CDC
|
NCI
|
2012
|
|
International Cancer Screening Network (ICSN)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI
|
2006
|
|
International Neonatal Consortium
|
Meeting/ Workshop
|
FDA
|
NICHD
|
2015
|
|
International Rare Diseases Research Consortium (IRDiRC) Funders' Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NEI, NHGRI, NIAMS, NICHD, NINDS
|
2011
|
|
International TB Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2014
|
|
Interoperability Standards Advisory Task Force of the Health Information Technology (HIT) Standards Committee
|
Committee, Advisory Group, or Work Group
|
IOS
|
NLM
|
2016
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIAID, OD/ ORS, OD/ OSP
|
2002
|
|
It’s a Noisy Planet. Protect Their Hearing® Public Education campaign
|
Public Education Campaign
|
CDC
|
NIDCD
|
2008
|
|
Joint Agency Nutrition Working Group (JAN)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ONR
|
2016
|
|
Joint External Evaluation Working Group (JEEWG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIEHS, NINDS, OD/ ORS, OD/ OSP
|
|
|
Journal of Women's Health Special Issue on Maternal Morbidity and Mortality
|
Research Initiative
|
ACF, HRSA, IHS, OASH
|
NCATS, NCCIH, NHLBI, NIA, NIAID, NICHD, NIDDK, NIEHS, NINR, NIMH, NIMHD, ODP, NIBIB, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
2019
|
|
Kaposi Sarcoma and HHV8 in Sickle Cell and Other Ugandan Populations
|
Research Initiative
|
CDC
|
NCI
|
2004
|
|
Kidney Innovation Accelerator (KidneyX)
|
Research Initiative
|
CMS, FDA
|
NIDDK
|
2018
|
|
Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCCIH, NCI, NHLBI, NIA, NICHD, NIDDK, NINDS
|
1987
|
|
Leprosy Research Support in Armadillos (Dasypus Novemcinctus)
|
Resource Development
|
HRSA
|
NIAID
|
2002
|
|
Leveraging Novel Technologies for Chronic Disease Management for Aging Underserved Populations
|
Research Initiative
|
OASH
|
NHLBI
|
2020
|
|
LGBT Healthy People 2030 Working Group (LGBT HP 2030)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NEI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, ODP, OD/ DPCPSI/ SGMRO
|
2019
|
|
Linkage of Surveillance, Epidemiology, End Results data to Centers for Medicare and Medicaid data
|
Resource Development
|
CMS
|
NCI
|
1990
|
|
Logical Observation Identifiers Names and Codes (LOINC)
|
Resource Development
|
AHRQ, CDC, CMS, HRSA, IHS, IOS
|
NLM
|
2003
|
|
Lower Limb Prosthetics Research Standards Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, CMS, FDA
|
NIDDK, NICHD, OD
|
|
|
Lung Scoring System
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC
|
NIAID
|
2020
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCIH, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2003
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Machine learning methods for literature data extraction
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
Mapping of the Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT) and International Classification of Disease (ICD) Clinical Terminology
|
Resource Development
|
CDC, IOS
|
NLM
|
2004
|
|
Materials Genome Initiative (MGI)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB
|
2018
|
|
Maternal Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NICHD, NIMHD, OD/ DPCPSI/ ORWH
|
2019
|
|
Medical Expenditure Panel Survey (MEPS): Experiences with Cancer Survivorship Supplement
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
NCI
|
2016
|
|
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2015
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Meta-Analysis Interagency Group (MATIG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NHLBI
|
2017
|
|
Microphysiological Systems for COVID Research (MPSCoRe): a joint working group to support global COVID-19 tissue chip activities
|
Resource Development
|
FDA
|
NIAID, NIEHS, NCATS
|
2020
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC
|
2012
|
|
Mind Your Risks
|
Public Education Campaign
|
CDC, CMS
|
NINDS
|
2015
|
|
Models of Infectious Disease Agent Study (MIDAS)
|
Research Initiative
|
CDC
|
FIC, NIAID, NIGMS
|
2003
|
|
Monthly Zika Vaccine Development Meeting
|
Resource Development
|
BARDA, FDA
|
NIAID
|
2018
|
|
Multinational Influenza Seasonal Mortality Study (MISMS) Research
|
Research Initiative
|
FDA, OS
|
FIC, NHLBI, NIAID, NLM
|
2001
|
|
Multiple Chronic Conditions eCare Plan Project
|
Resource Development
|
AHRQ, ASPE
|
NIDDK
|
2019
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
My Family Health Portrait (MFHP)
|
Resource Development
|
CDC
|
NCI, NHGRI
|
2005
|
|
MyHealthfinder Steering Committee
|
Committee, Advisory Group, or Work Group
|
IOS/ODPHP
|
NLM
|
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
NAPA Federal Research Subgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, ASPE, ACL, CDC, CMS, FDA, HRSA, IHS
|
NIA, NINDS
|
|
|
NASEM Aging Disability and Independence Forum
|
Committee, Advisory Group, or Work Group
|
ACL
|
NIA
|
2014
|
|
National Academies Addressing Evidence Gaps in Clinical Prevention (NAM Evidence Gaps project)
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
ODP
|
2020
|
|
National Academy of Medicine Committee on Emerging Science, Technology, and Innovation in Health and Medicine
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH
|
2020
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/ DPCPSI/ OBSSR, ODP
|
2010
|
|
National Action Plan for Combating Antoibiotic-Resistant Bacteria (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Action Plan for the Elimination of multi-drug resistant Tuberculosis (MDR TB)
|
Other
|
CDC
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA
|
2015
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Advisory Committee on Children and Disasters (NAACD)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, ASPR
|
NICHD, NIEHS
|
|
|
National Amyotrophic Lateral Sclerosis Registry
|
Resource Development
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Cancer Institute and HRSA Office of Women’s Health
Cervical Cancer Moonshot Roundtable Series:
Creating Capacity to Reduce Systems Barriers in Rural and Underserved Settings
|
Committee, Advisory Group, or Work Group
|
OASH, HRSA
|
NCI
|
2020
|
|
National Center for Advancing Translational Sciences (NCATS) Patient-focused Therapeutics Development Toolkit
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Care Commission (NCCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
2018
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, ODP
|
2010
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Death Index Linkage Collaboration (NIH-NDI Agreement)
|
Resource Development
|
CDC
|
OD/ DPCPSI/ OBSSR, OD/ IMOD
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NCATS, NCI, NHLBI, NIA, NIAID, NIDA, NICHD, NIMH, OD/ DPCPSI/ OBSSR
|
2018
|
|
National Emerging Contaminant Research Initiative
|
Research Initiative
|
CDC, ATSDR, FDA
|
NIEHS
|
|
|
National Family Health History Group
|
Public Education Campaign
|
CDC
|
CC, NHGRI, OD/ OSP
|
2005
|
|
National Health Interview Survey (NHIS) Cancer Control Supplement
|
Health Survey
|
CDC
|
NCI
|
1992
|
|
National Healthcare Quality and Disparities (NHQDR) Inter-Agency Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, HRSA
|
NCI, NIAID, NIEHS, NIMHD
|
2004
|
|
National Hispanic Science Network (NHSN)
|
Meeting/ Workshop
|
AHRQ, CDC, SAMHSA
|
NIAAA, NIDA, NIMH
|
2001
|
|
National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations
|
Resource Development
|
AHRQ, CDC, CMS
|
NIDCD
|
1995
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCI, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Institutes of Health (NIH) Metabolomics Scientific Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIA, NIAAA, NIAID, NIDCR, NIDDK, NIEHS, NIMH, NLM, OD/ DPCPSI/ ODS
|
2007
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
, NIAID, NCI
|
2002
|
|
National Neurological Conditions Surveillance System (NNCSS)
|
Research Initiative
|
CDC
|
NINDS
|
2016
|
|
National Pain Strategy. Provider Eduction Committee (NPS)
|
Meeting/ Workshop
|
CDC, HRSA, FDA, OASH
|
NINDS, OD/ DPCPSI/ ORWH
|
2016
|
|
National Response Team (NRT)
|
Resource Development
|
ASPR, ATSDR, CDC
|
NIEHS
|
2003
|
|
National Robotics Initiative (NRI)
|
Research Initiative
|
CDC
|
NCATS, NEI, NIA, NIBIB, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
National Science and Technology Council Subcommittee on Open Science (NSTC SOS)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPR, CDC, FDA
|
NLM, OD/ OSP, OD/ OER
|
|
|
National Security Staff Dual Use Research of Concern Interagency Policy Committee (NSS DURC PCC)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OSP
|
|
|
National Security Staff Dual Use Research of Concern Sub-Interagency Policy Committee (NSS DURC Sub-PCC)
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
NIAID, OD/ OSP
|
|
|
National Sexually Transmitted Infections (STI) Strategic Plan
|
Committee, Advisory Group, or Work Group
|
OASH, ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID
|
2020
|
|
National Survey of Family Growth
|
Health Survey
|
ACF, CDC
|
NICHD
|
1973
|
|
National Toxicology Board of Scientific Counselors (NTP BSC)
|
Meeting/ Workshop
|
CDC, FDA
|
NIEHS
|
1978
|
|
National Toxicology Program Executive Committee (NTP EC)
|
Meeting/ Workshop
|
ATSDR, CDC, FDA, OASH
|
NIEHS
|
1978
|
|
National Toxicology Program Steering Committee (NTP SC)
|
Meeting/ Workshop
|
CDC, FDA
|
NIEHS
|
2003
|
|
Native American Research Center for Health (NARCH)
|
Research Initiative
|
IHS
|
CSR, NCI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2000
|
|
Natural Compounds to Reduce Nitrate in Meat Products: Phytome
|
Research Initiative
|
CDC
|
NCI
|
2016
|
|
Natural Experiments and Effectiveness Studies in the Prevention and Control of Diabetes
|
Research Initiative
|
CDC
|
NIDDK
|
2010
|
|
NCHS-CDC-NHANES, Audiometry, Balance, and Words in Noise Component
|
Health Survey
|
CDC
|
NIDCD
|
2018
|
|
NCI Cancer Data Standards Repository and Registry (caDSR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CIT, NCI, NEI, NHLBI, NIAMS, NIBIB, NICHD, NIMH, NINDS, NLM, NCATS
|
2003
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI Convenes Workshop on Reproducibility of Fecal Microbiota Transplants in Cancer Therapeutics
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID
|
2019
|
|
NCI Scientific Steering Committees (SSCs)
|
Research Initiative
|
FDA
|
NCI
|
2011
|
|
NCI's Surveillance, Epidemiology and End Results (SEER) cancer registry data and the Centers for Medicare & Medicaid Services' (CMS) Medicare Consumer Assessment of Healthcare Providers and Systems (CAHPS®) patient surveys.
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCI
|
2013
|
|
NCI/CCR-FDA Clinical Investigator Program
|
Research Initiative
|
FDA
|
NCI
|
2015
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
NCI/FDA/HRSA/CMS Task Force on Cancer Diagnostic Devices (CD2) for Near-Patient Use
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, HRSA
|
NCI
|
2019
|
|
Networking and Information Technology Research and Development (NITRD)
|
Research Initiative
|
AHRQ
|
NIGMS
|
1991
|
|
Neutron Radiobiology and Dosimetry Workshop Meeting Report
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
2017
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, FDA, HRSA, IOS
|
NHGRI, NHLBI, NICHD, NLM
|
2007
|
|
Newborn Screening Federal Partners Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHGRI, NLM
|
2009
|
|
NGSP (formerly the National Glycohemoglobin Standardization Program)
|
Resource Development
|
CDC
|
NIDDK
|
1996
|
|
NHANES 2011-14 Accelerometer Data
|
Health Survey
|
CDC
|
NCI, NIA, NIDDK, NHLBI, OD/ DPCPSI/ OBSSR, ODP, OD/ DPCPSI/ ORWH
|
2009
|
|
NIA IMPACT Collaboratory Transforming Dementia Care
|
Research Initiative
|
CDC
|
NIA
|
2019
|
|
NIAID-CDC Joint US Partnership Implementing TB Elimination Research (JUPITER)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2007
|
|
NIAID/Armed Forces Radiobiology Research Institute (AFRRI) Research Coordination Team (RCT)
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2012
|
|
NIAID/CDC Dual Use Research of Concern (DURC) Risk Mitigation Reviews
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2015
|
|
NIAID/FDA/BARDA Meeting on Cutaneous Radiation Injuries
|
Meeting/ Workshop
|
BARDA, FDA
|
NIAID, NIGMS
|
2018
|
|
NIAID/FDA/BARDA Meeting on Radiation-Induced Lung Injuries
|
Meeting/ Workshop
|
FDA, ASPR
|
NIAID
|
2018
|
|
NIAID/NASA Medical Countermeasures Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NIAID, NCI, NHLBI
|
2017
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIEHS SBIR PHASE IIB Awards for Validation and Commericialization of Approaches to Reduce Animal Use in Toxicology Testing (U44)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIEHS
|
2016
|
|
NIH American Indian and Alaska Native Health Communications and Information Work Group
|
Committee, Advisory Group, or Work Group
|
ACL, IHS
|
NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ THRO
|
2005
|
|
NIH Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID, OD, NCI, NCATS, NCCIH, NEI, NHLBI, NHGRI, NIAMS, NIBIB, NIEHS
|
2003
|
|
NIH Common Data Elements Task Force (CDETF)
|
Committee, Advisory Group, or Work Group
|
AHRQ, FDA, CMS
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NCRR, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODSS, OD/ OER
|
2012
|
|
NIH COVID-19 Treatment Guidelines Panel
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2020
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH Medical Rehabilitation Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA
|
CC, CSR, NCCIH, NCI, NEI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIMH, NINDS, NINR
|
1999
|
|
NIH Scientific Data Council for the Common Data Elements (CDE) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
CC, CIT, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ SGMRO, OD/ OER, OD/ OSP
|
|
|
NIH, HUD, CDC Housing and Health Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NICHD, NIDDK, ODP
|
2019
|
|
NIH-BARDA Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2018
|
|
NIH-CDC-IDSA Guidelines for Treatment of HIV Related Opportunistic Infections Among Adults and Adolescents
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, OD/ DPCPSI/ OAR
|
1989
|
|
NIH-FDA Interagency Clinical Outcome Assessments (ICOA) Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCCIH, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
NIH-FDA Medical Device Research Interest Group (MDRIG)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCATS, NCI, NEI, NHLBI, NIA, NIAID, NIBIB, NICHD, NIDDK, NINR, OD/ DPCPSI/ ORIP, FIC, NIAMS, NIDA
|
2016
|
|
NIH/BARDA Antimicrobial Resistance (AMR) Diagnostic Challenge Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA, CDC
|
NIAID
|
2015
|
|
NIH/BMGF Collaboration - Point of Care Testing Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI, NIAID, NIBIB, NICHD
|
2016
|
|
NINDS Common Data Elements Program
|
Resource Development
|
CDC, FDA
|
CIT, NINDS, NICHD, NEI, NHGRI, NCATS, NIA, NIMH, NIEHS, NIGMS, NIBIB, NIDDK, NIDCR, NINR, NHLBI
|
2006
|
|
Non-animal approaches to assess cardiotoxicity hazard
|
Research Initiative
|
FDA
|
NIEHS
|
2018
|
|
Northwest Portland Tribal Registry Project
|
Resource Development
|
IHS
|
NCI
|
1999
|
|
NSTC Subcommittee on Biological Defense Research and Development - Interagency Bioconvergence Working Group
|
Committee, Advisory Group, or Work Group
|
OS
|
OD/ OSP
|
2020
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
OD/ OSP
|
|
|
NSTC Subcommittee on Biological Sciences -Interagency Synthetic Biology Working Group (BSSC-SBWG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIBIB, OD/ OSP
|
2019
|
|
Nutrition Research Coordinating Committee (NRCC)
|
Committee, Advisory Group, or Work Group
|
ACL, AHRQ, ASPE, CDC, FDA, HRSA, OASH
|
OD/ DPCPSI/ ONR
|
1975
|
|
Obesity Prevention and Control: Combined School-Based Interventions to Increase Healthier Food and Beverage Consumption and Physical Activity
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
2018
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
2018
|
|
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
|
Research Initiative
|
CDC
|
NIEHS
|
2020
|
|
Office for Human Research Protections/Office of Extramural Research Training Initiative
|
Meeting/ Workshop
|
OS
|
OD/ OER
|
2011
|
|
Office of AIDS Research Advisory Council (OARAC)
|
Committee, Advisory Group, or Work Group
|
CDC
|
OD, NIAID, OD/ DPCPSI, OD/ DPCPSI/ OAR
|
2007
|
|
Office of Justice Programs/HHS Medicolegal Death Investigation Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC, NIAID, NICHD
|
2020
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, OSG
|
NCI, NIBIB
|
2011
|
|
Office of Secretary, Patient-Centered Outcomes Research Trust Fund (OS-PCORTF) PCORTF Projects titled, “Data Capacity for PCOR through eCare Planning for People with Multiple Chronic Conditions & Disability.”
|
Resource Development
|
ACL, AHRQ, IHS
|
NCI, NHLBI, NIA, NIDDK, NLM
|
2017
|
|
Operation War Speed - Model Assessment Team
|
Committee, Advisory Group, or Work Group
|
ASPR
|
NIAID
|
2020
|
|
Operation War Speed - Preclinical Vaccine Team
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
Operation War Speed - Preclinical Vaccine Team - Product Assessment subteam
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
Operation Warp Speed (OWS)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Operation Warp Speed - Vaccine Development Team
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
Operation Warp Speed - Vaccine Development Team - Immune Assays Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2020
|
|
Operation Warp Speed COVID-19 Research Group (now the USG COVID-19)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ASPR
|
NIAID
|
2020
|
|
Oral Health & Aging: Information for Caregivers
|
Public Education Campaign
|
ACL, HRSA, IOS
|
NIA, NIDCR
|
2018
|
|
ORWH E-learning courses
|
Training Initiative
|
FDA
|
NIGMS, OD/ DPCPSI/ ORWH
|
2020
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Pathogen Detection Project and Interagency Collaboration on Genomics for Food and Feed Safety (Gen-FS)
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Pathways to Prevention (P2P) Workshop Program
|
Meeting/ Workshop
|
AHRQ
|
ODP
|
2012
|
|
Patient Centered Outcomes Research Trust Fund Leadership Council (OS-PCORTF LC)
|
Committee, Advisory Group, or Work Group
|
ASPE, CMS, AHRQ, ACF, ACL, CDC, FDA, HRSA, ONC, IHS
|
NCCIH, NLM, OD/ DPCPSI, OD/ OER
|
2012
|
|
PCC Technical Working Group on PFAS
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, ATSDR
|
NIEHS
|
|
|
PCORTF Frailty & Functional Disabilities Project Working Group
|
Resource Development
|
ASPE, AHRQ, CDC, CMS
|
NIA
|
2019
|
|
Pediatric COVID-19/Multisystem Inflammatory Syndrome in Children (MIS-C) interagency team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NHLBI, NIAID, NICHD
|
2020
|
|
Pediatric Device Consortia Grants Program
|
Research Initiative
|
FDA
|
NICHD
|
2009
|
|
Phylodynamic Monitoring of HIV Transmission Hotspots to End the HIV Epidemic
|
Meeting/ Workshop
|
CDC
|
NLM
|
2019
|
|
Pillbox
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
Planning and Design for Post-Acute Care Assessment Instruments and Data Elements
|
Resource Development
|
CMS
|
NLM
|
2007
|
|
Policies and Regulatory Pathways to FDA Licensure
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2018
|
|
Polyhalogenated Aromatic Hydrocarbons (PHAH) and Thyroid Cancer
|
Research Initiative
|
CDC
|
NCI
|
2010
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Post Market Safety Study of Opioids
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA, OD/ DPCPSI/ ORWH
|
2014
|
|
Post-Traumatic Stress Disorder (PTSD)/Trauma Brain Injury (TBI), Suicide Prevention National Research Action Plan (NRAP) Workgroup
|
Committee, Advisory Group, or Work Group
|
OS
|
NIAAA, NIDA, NIMH, NINDS
|
2012
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Predictive Biodosimetry Guidance Planning Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIAID
|
2020
|
|
Pregnancy and Birth to 24 Months (P/B-24) Project
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2012
|
|
Pregnancy and Maternal Conditions that Increase Risk of Morbidity and Mortality Virtual Workshop
|
Meeting/ Workshop
|
OASH
|
NICHD, NHLBI, ODP, OD/ DPCPSI/ ORWH
|
2020
|
|
Pregnancy Risk Assessment Monitoring System: Addition of Disability Questions
|
Health Survey
|
CDC
|
NICHD
|
2019
|
|
PregSource® Management Team
|
Public Education Campaign
|
CDC, HRSA
|
NCCIH, NHLBI, NICHD, NIEHS, NIMHD, NINR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2017
|
|
President's Advisory Council for HIV/AIDS (PACHA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, HRSA, IHS, OASH
|
OD/ DPCPSI/ OAR
|
2016
|
|
President's Emergency Plan for AIDS Relief (PEPFAR) Implementation Science/Combination Prevention
|
Research Initiative
|
CDC
|
FIC, NCI, NIAAA, NIAID, NIDA, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children (PTFCEH)
|
Committee, Advisory Group, or Work Group
|
ACF, ASPR, CDC, ATSDR, FDA, OASH, SAMHSA
|
NICHD, NIEHS, NHLBI, NIMH, NIMHD
|
|
|
President's Task Force on Environmental Health Risks and Safety Risks to Children: Lead Exposures Subcommittee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, OS
|
NHLBI, NICHD, NIEHS, ODP
|
|
|
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
|
Committee, Advisory Group, or Work Group
|
BARDA
|
NIAID
|
2015
|
|
Prevention Research Coordinating Committee (PRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ ODS, OD/ OLPA, ODP
|
1997
|
|
Probiotic and Prebiotic Working Group [PPWG]
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NCI, NIAMS, NIDA, NIDCR, OD/ DPCPSI/ ODS
|
2006
|
|
Project ECHO for Cancer Research and Control
|
Resource Development
|
CDC
|
NCI
|
2018
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Management Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, IOS, SAMHSA
|
NIAMS, NLM
|
2008
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Pediatrics and Obstetrics Integrated Program Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD, NIGMS
|
2006
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Quantitative Data Mining for Drug-Adverse Event Safety Signal Detection Using MEDLINE
|
Research Initiative
|
FDA
|
NLM
|
2012
|
|
Quantum Barcoding for analysis of Ebola infection
|
Resource Development
|
FDA
|
NIAID
|
2019
|
|
Racial/Ethnic Variation of HPV Type Distribution in High-Grade Cervical Precancers and Invasive Cancers in the United States
|
Research Initiative
|
CDC
|
NCI
|
2016
|
|
Radiation and Chemical Defense Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, FDA
|
NIAID, NIEHS, NIAMS
|
2020
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiation Emergency Medical Management (REMM)
|
Resource Development
|
CDC, IOS, ASPR
|
NCI, NLM
|
2005
|
|
Radiation-Induced Immune Dysfunction Meeting
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
2019
|
|
Radiation-Induced Multi Organ Dysfunction Meeting Planning Group
|
Meeting/ Workshop
|
ASPR
|
NCI, NIAID
|
2020
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Meeting/ Workshop
|
FDA, OS
|
NCI, NIAID
|
2003
|
|
Rapid Acceleration of Diagnostics Tech Program (RADx Tech)
|
Research Initiative
|
CMS, FDA, CDC, ASPR
|
NIBIB
|
2020
|
|
Rare Disease Day at NIH
|
Meeting/ Workshop
|
FDA
|
NCATS, NHLBI, NCI, NHGRI, NICHD, NINDS, CC
|
2017
|
|
rCR training to Grants Managers
|
Training Initiative
|
OASH
|
OD/ OER
|
2020
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
2007
|
|
Recognize, Assist, Include, Support and Engage (RAISE) Family Caregiving Advisory Council
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIA
|
2018
|
|
Reentry Research Network
|
Committee, Advisory Group, or Work Group
|
ACF, SAMHSA
|
NIDA, OD/ DPCPSI/ OBSSR
|
2012
|
|
Regenerative Medicine Innovation Project Senior Oversight Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS
|
2018
|
|
Regenerative Medicine Project
|
Research Initiative
|
FDA
|
NIA
|
2017
|
|
Registry-based studies of hematologic malignancy incidence and survivorship
|
Research Initiative
|
FDA
|
NCI
|
2019
|
|
Report Out Session of the HIV-related Intersectional Stigma Research Advances and Opportunities Workshop
|
Meeting/ Workshop
|
OASH
|
NIMH, OD/ DPCPSI/ OAR
|
2020
|
|
RePORT South Africa
|
Research Initiative
|
CDC, OS
|
NIAID
|
2016
|
|
Repurposing Off-Patent Drugs: Research & Regulatory Challenges
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2019
|
|
Research in Diabetes Mellitus, Its Complications, and Obesity
|
Research Initiative
|
IHS
|
NIDDK
|
1965
|
|
Research IND Portal ( Pilot)
|
Resource Development
|
FDA
|
NCI
|
2019
|
|
Research to Guide Practice Enhancing HIV/AIDS Platforms to Address Non- Communicable Diseases in Low Resource Settings (HIV/NCD Integration Project)
|
Research Initiative
|
CDC
|
FIC, NCI, NHLBI, NIAID, NICHD, NIDDK, NIMH, NIMHD, NINDS, NINR, OD/ DPCPSI/ OAR
|
2014
|
|
Review of Applications for the Biomedical Data Translator: Development Phase
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NHGRI, NIDDK, NLM
|
2019
|
|
Review Policy Committee (RPC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC
|
CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, NIDCD, OD, OD/ OER
|
|
|
Revision of Centers for Disease Control and Prevention (CDC) Guidelines on Hepatitis B
|
Committee, Advisory Group, or Work Group
|
CDC
|
CC
|
2011
|
|
Role of IFNL4 in immune response to infection
|
Research Initiative
|
FDA
|
NCI
|
2018
|
|
Ruth L. Kirschstein National Research Service Award Program
|
Training Initiative
|
AHRQ, HRSA
|
OD/ OER
|
1985
|
|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
2009
|
|
Safe to Sleep
|
Public Education Campaign
|
CDC, HRSA
|
NICHD
|
1994
|
|
SAMHSA Recovery Month
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
1989
|
|
SARS-CoV-2 Antiviral Summit
|
Meeting/ Workshop
|
FDA
|
NCATS
|
2020
|
|
SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
2020
|
|
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
|
Resource Development
|
CDC
|
NLM
|
2020
|
|
SEARCH for Diabetes in Youth
|
Research Initiative
|
CDC
|
NIDDK
|
2001
|
|
Seasonal Influenza Vaccine Improvement Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2010
|
|
Secretary's Advisory Committee on Infant Mortality
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
|
|
Senior Medical Advisor to Assistant Secretary for Preparedness and Response (ASPR)
|
Committee, Advisory Group, or Work Group
|
OS
|
NCI, NIAID
|
2004
|
|
Sepsis Interagency Meeting
|
Meeting/ Workshop
|
AHRQ, BARDA, CDC, CMS
|
CC, NHLBI, NIAID, NICHD, NIGMS
|
2019
|
|
Sex Differences Meeting Planning Committee
|
Meeting/ Workshop
|
BARDA
|
NIAID, OD/ DPCPSI/ ORWH
|
2020
|
|
SHIELD – Standardization of Lab Data to Enhance Outcomes Research and Value Based Care
|
Committee, Advisory Group, or Work Group
|
FDA
|
NLM
|
|
|
Smokefree.gov
|
Resource Development
|
CDC, FDA, IHS
|
NCI, NIMHD, OD/ DPCPSI/ OBSSR
|
2003
|
|
Society for Prevention Research Annual Meetings
|
Meeting/ Workshop
|
ACF, CDC
|
NCI, NIAAA, NICHD, NIDA, OD/ DPCPSI/ OBSSR, ODP
|
1991
|
|
Society for Prevention Research R13 Conference Award (R13AA025540)
|
Meeting/ Workshop
|
ACF, CDC
|
NCCIH, NCI, NIAAA, NIDA, OD/ DPCPSI/ OBSSR, ODP
|
2017
|
|
Somatic Cell Genome Editing
|
Research Initiative
|
FDA
|
NCATS, NCI, NHGRI, NHLBI, NIAID, NIAMS, NIDDK, NIMH, NINDS, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ OSC
|
2017
|
|
Specificity and Quality of Influenza-Specific Antibodies
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Standardized Machine-Readable Units of Measure
|
Committee, Advisory Group, or Work Group
|
IOS
|
NLM
|
2016
|
|
Standards for Genetic Testing Report
|
Research Initiative
|
AHRQ, CDC, IOS
|
NHGRI, NLM
|
2007
|
|
State Cancer Profiles
|
Resource Development
|
CDC
|
NCI
|
2004
|
|
State of Illinois - Governor's Challenge
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
CC
|
2020
|
|
Steering Committee Meeting for PAR 18-947. “Integrating Biospecimen Science Approaches into Clinical Assay Development”
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2020
|
|
Steering Committee of the Scientific Interest Group in Glycobiology
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIGMS
|
2008
|
|
Stimulating Peripheral Activity to Relieve Conditions
|
Research Initiative
|
FDA
|
NCATS, NCCIH, NCI, NEI, NHLBI, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIMH, NINDS, OD/ DPCPSI/ OSC
|
2016
|
|
Structured Data Capture (SDC) Initiative
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS
|
NCATS, NCI, NLM
|
2013
|
|
Sudden Death in the Young (SDY) Registry
|
Resource Development
|
CDC, HRSA
|
NHLBI, NINDS
|
2013
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, IOS
|
NLM, OD/ OSP
|
2013
|
|
Supporting Early Psychosis Research and Implementation
|
Research Initiative
|
OS
|
NIMH
|
2018
|
|
Supporting the Whole Student: Mental Health and Well-Being in STEMM Undergraduate and Graduate Education
|
Committee, Advisory Group, or Work Group
|
SAMHSA
|
NIAAA, NIDA, NIMH
|
2019
|
|
Surveillance, Epidemiology and End Results (SEER) cancer registry and the Centers for Medicare & Medicaid Services' (CMS) Medicare Health Outcomes Survey (MHOS)
|
Committee, Advisory Group, or Work Group
|
CMS
|
NCI
|
2011
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
NCI
|
1973
|
|
Synthetic DNA Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2018
|
|
System of Hospitals for Innovation in Pediatrics - Medical Devices (SHIP-MD)
|
Meeting/ Workshop
|
FDA
|
NICHD
|
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
NLM
|
2003
|
|
Task Force for Combating Antibiotic-Resistant Bacteria (CARB)
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA
|
NIAID
|
2014
|
|
Task Force on Research Specific to Pregnant Women and Lactating Women
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, SAMHSA
|
NCATS, NHLBI, NIAID, NICHD, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2017
|
|
Technical and Clinical Consultation to Indian Health Service in Kidney Disease
|
Other
|
IHS
|
NIDDK
|
2006
|
|
Technical Consultation on Viral Hepatitis (HCV) Infection in Young Injection Drug Users
|
Meeting/ Workshop
|
CDC, OS, SAMHSA
|
NIAID, NIDA, NIDDK
|
2012
|
|
Technical Expert Panel on Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: Groundwork for a Publicly Available Repository of Randomized Controlled Trials
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NIMH
|
2018
|
|
Technical Expert Panel on the development of Evidence-Based Practice Guide on the treatment of serious mental illness (SMI) in older adults.
|
Meeting/ Workshop
|
SAMHSA
|
NIMH
|
2021
|
|
Technology Transfer Policy Board (TTPB)
|
Other
|
FDA, CDC, OGC
|
OD/ OSP, OD/ OIR, OD/ OER
|
1995
|
|
Terminology Standards for Medicare Assessment Instruments
|
Resource Development
|
CMS
|
NLM
|
2014
|
|
The APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Steering Committee Meetings
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID, NIDDK, NIMH
|
2018
|
|
The Assay Guidance Manual
|
Resource Development
|
FDA
|
NCATS
|
2020
|
|
The Assistant Secretary for Preparedness and Response (ASPR)'s chemical, biological, radiological and nuclear defense team
|
Committee, Advisory Group, or Work Group
|
OS
|
NCI, NIAID
|
2004
|
|
The Centers for Disease Control and Prevention (CDC)'s Field Epidemiology Training Program (FETP) Cancer Curriculum
|
Training Initiative
|
CDC
|
NCI
|
2012
|
|
The Effect of Various Drugs on the Retina
|
Research Initiative
|
FDA
|
NEI
|
2014
|
|
The Environmental Determinants of Diabetes in the Young (TEDDY)
|
Research Initiative
|
CDC
|
NIAID, NICHD, NIDDK, NIEHS
|
2002
|
|
The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM)
|
Research Initiative
|
CDC, FDA
|
NCI, NHGRI, NHLBI
|
2010
|
|
The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
|
Research Initiative
|
CDC
|
NIDDK
|
2016
|
|
The Golestan Cohort Study of Esophageal Cancer
|
Research Initiative
|
CDC
|
NCI
|
2018
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Incidence of Breast and Other Cancers Among Female Flight Attendants
|
Research Initiative
|
CDC
|
NCI
|
1998
|
|
The MDEpiNet TMJ RoundTable
|
Meeting/ Workshop
|
AHRQ, FDA
|
NIDCR
|
2016
|
|
The NIH Helping to End Addiction Long Term (HEAL) Initiative
|
Research Initiative
|
AHRQ, CDC, CMS, HRSA, OS, SAMHSA
|
NCATS, NCCIH, NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ OSP
|
2018
|
|
The President’s Roadmap to Empower Veterans and End a National Tragedy of Suicide (PREVENTS) Task Force
|
Committee, Advisory Group, or Work Group
|
CDC, IHS, SAMHSA, AHRQ
|
NIMH, NINDS, OD/ DPCPSI/ OBSSR
|
2019
|
|
The Scientific Registry of Transplant Recipients (SRTR) Visiting Committee
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID
|
2011
|
|
The United States Renal Data System (USRDS)
|
Resource Development
|
CMS, HRSA
|
NIDDK
|
1998
|
|
The wireless sensing and artificial intelligence (AI) for smart healthcare Work Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIBIB
|
2018
|
|
Tissue Chip Testing Centers
|
Research Initiative
|
FDA
|
NCATS
|
2016
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, SAMHSA, FDA
|
FIC, NCI, NEI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIEHS, NIMHD, NIGMS, NLM, OD/ DPCPSI, ODP
|
2003
|
|
Tobacco Centers of Regulatory Science (TCORS)
|
Research Initiative
|
FDA
|
ODP
|
2013
|
|
Tobacco Product Disease Risks
|
Research Initiative
|
FDA
|
NCI
|
2016
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIEHS, OD/ OER, ODP
|
2012
|
|
Tobacco Use Supplement to Current Population Survey
|
Health Survey
|
CDC, FDA
|
NCI, NIMHD
|
1992
|
|
Tox 21
|
Resource Development
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Toxicology in the 21st Century Federal Consortium
NTP – NCATS Interagency Agreement, ES-7020-01, Year 11 (Tox21)
|
Other
|
FDA
|
NIEHS, NCATS
|
2007
|
|
Toxin Working Group of the Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Toxins Assessment Working Group
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
NIAID
|
2019
|
|
Training Advisory Committee (TAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ ORIP, OD/ OER
|
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
BARDA, CDC, FDA
|
NIAID
|
2009
|
|
Trans-National Institutes of Health (NIH) Tuberculosis (TB) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NCATS, NCI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIGMS, OD/ DPCPSI/ OAR
|
|
|
Trans-NIH Structural Birth Defects Working Group (SBDWG)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS
|
2014
|
|
Trans-NIH Working Group for Objective Measures in Cancer
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB, NIDDK
|
2017
|
|
Translational Science Interagency Fellowship
|
Training Initiative
|
FDA
|
NCATS
|
2030
|
|
Transplant Cancer Match Study
|
Research Initiative
|
HRSA
|
NCI
|
2005
|
|
Trial to Assess Chelation Therapy 2 (TACT2)
|
Research Initiative
|
CDC
|
NCCIH, NHLBI, NIDDK, NIEHS
|
2016
|
|
Tribal Epidemiology Centers Program
|
Research Initiative
|
IHS, CDC
|
NIMHD, OD/ DPCPSI/ THRO
|
2002
|
|
Tribal Health Research Advisory Council (HRAC)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA
|
NIMHD, OD/ DPCPSI/ THRO
|
2006
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NIAID
|
2013
|
|
U.S. Burden of Health Disparities Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NHLBI, NIA, NIMHD, OD/ DPCPSI/ OBSSR, ODP, NIAMS
|
|
|
U.S. FDA Medical Imaging Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC
|
2015
|
|
Understanding and Identifying the Needs for Medical Devices
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2014
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
1990
|
|
United States Government Children in Adversity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, ACF
|
FIC, NICHD, NIEHS, NIMH
|
2011
|
|
United States Government Global Nutrition Coordination Plan
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2016
|
|
Urine biomarkers and risk of lung cancer in the Sisters Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
2019
|
|
Urine biomarkersof tobacco and opium and risk of cancers anad heart disease
|
Research Initiative
|
CDC, FDA
|
NCI
|
2020
|
|
US Government Inter agency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIEHS
|
2005
|
|
US Preventive Services Task Force (USPSTF)
|
Resource Development
|
AHRQ
|
NCI, ODP
|
2001
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAID
|
2015
|
|
USDA-HHS Birth to 24 Months & Pregnant Women Project Federal Expert Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, ODP
|
2012
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
NIMH
|
2019
|
|
Vaccines and Related Blood Products Advisory Committee (VRBPAC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2018
|
|
Validation study of the electrophilic allergen screening assay
|
Research Initiative
|
FDA
|
NIEHS
|
2017
|
|
Value Set Authority Center (VSAC)
|
Resource Development
|
AHRQ, CDC, CMS, IOS
|
NLM
|
2012
|
|
Violence Against Women Steering Committee (DHHS VAW)
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA, SAMHSA, ACF, ACL, AHRQ, CMS, IHS, OASH
|
NIA, NIDA, NIAAA, NICHD, NIMH, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
|
|
Virology Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMH, NINDS
|
1994
|
|
Vision Research Collaborative
|
Research Initiative
|
FDA
|
NEI
|
2020
|
|
WHO Risk Assessment Netword
|
Public Education Campaign
|
CDC
|
NIEHS
|
|
|
Why has progress in hypertension control plateaued in the United States, and how can progress be restarted? Establishing a Research Agenda for the 2020’s
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
2019
|
|
Working Groups to Develop HIV/AIDS Treatment and Prevention Guidelines
|
Committee, Advisory Group, or Work Group
|
OASH
|
CC, NIAID, NICHD, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR
|
2005
|
|
World Cancer Research Day, HPVAware, and World No Tobacco Day, World Cancer Day observances
|
Public Education Campaign
|
OS
|
FIC, NCI
|
2017
|
|
World Health Organization (WHO) Programme on Prevention of Deafness and Hearing Loss
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIDCD
|
2017
|
|
Zoster Working Group of the CDC Advisory Committee for Immunization Practices (ACIP)
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2010
|
|
|